CL2015003169A1 - Anticuerpos anti-cd38 y fusiones con interferón alfa-2b atenuado - Google Patents

Anticuerpos anti-cd38 y fusiones con interferón alfa-2b atenuado

Info

Publication number: CL2015003169A1
Authority: CL; Chile
Prior art keywords: fusions; antibodies; interferon alfa; attenuated interferon; attenuated
Prior art date: 2015-10-28

Application number

CL2015003169A

Other languages

English (en)

Inventor

Adam Clarke

Matthew Pollard

Anthony Gerard Doyle

Collette Behrens

Tetsuo Yamagishi

David S Wilson Jr

Sarah L Pogue

Tetsuya Taura

Original Assignee

Teva Pharmaceuticals Australia Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-10-28

Filing date

2015-10-28

Publication date

2016-05-13

2015-10-28 Application filed by Teva Pharmaceuticals Australia Pty Ltd filed Critical Teva Pharmaceuticals Australia Pty Ltd

2015-10-28 Priority to CL2015003169A priority Critical patent/CL2015003169A1/es

2016-05-13 Publication of CL2015003169A1 publication Critical patent/CL2015003169A1/es

Links

108010078049 Interferon alpha-2 Proteins 0.000 title 1
230000002238 attenuated effect Effects 0.000 title 1
230000004927 fusion Effects 0.000 title 1
229960003507 interferon alfa-2b Drugs 0.000 title 1
MIXCUJKCXRNYFM-UHFFFAOYSA-M sodium;diiodomethanesulfonate;n-propyl-n-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide Chemical compound [Na+].[O-]S(=O)(=O)C(I)I.C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl MIXCUJKCXRNYFM-UHFFFAOYSA-M 0.000 title 1

CL2015003169A 2015-10-28 2015-10-28 Anticuerpos anti-cd38 y fusiones con interferón alfa-2b atenuado CL2015003169A1 (es)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CL2015003169A CL2015003169A1 (es)	2015-10-28	2015-10-28	Anticuerpos anti-cd38 y fusiones con interferón alfa-2b atenuado

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CL2015003169A CL2015003169A1 (es)	2015-10-28	2015-10-28	Anticuerpos anti-cd38 y fusiones con interferón alfa-2b atenuado

Publications (1)

Publication Number	Publication Date
CL2015003169A1 true CL2015003169A1 (es)	2016-05-13

Family

ID=56081083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2015003169A CL2015003169A1 (es)	2015-10-28	2015-10-28	Anticuerpos anti-cd38 y fusiones con interferón alfa-2b atenuado

Country Status (1)

Country	Link
CL (1)	CL2015003169A1 (es)

2015
- 2015-10-28 CL CL2015003169A patent/CL2015003169A1/es unknown

Similar Documents

Publication	Publication Date	Title
IL283321A (en)	2021-07-29	Antibodies against muc16 and their uses
ZA201707138B (en)	2022-11-30	Anti-ceacam6 antibodies and uses thereof
IL258284A (en)	2018-05-31	Anti-Lag 3 antibodies and their uses
DK3677591T3 (da)	2023-03-20	Anti-CD38 antistoffer og fusioner til svækket interferon alpha-2b
IL257263A (en)	2018-03-29	Antibodies against angptl8 and their use
ZA201800536B (en)	2019-07-31	Il-8-binding antibodies and uses thereof
LT3827845T (lt)	2022-06-10	Poodinės anti-cd38 antikūnų kompozicijos ir jų naudojimas
IL254954A0 (en)	2017-12-31	Anti-pacap antibodies and their uses
ZA201700483B (en)	2018-12-19	Interferon alpha and omega antibody antagonists
IL257323B1 (en)	2023-09-01	New antibodies against human gpvi and their uses
IL262244A (en)	2018-11-29	Antibodies against beta interferon and their use
PL3292154T3 (pl)	2022-04-19	Przeciwciała przeciwko ludzkiemu HER3 i ich zastosowania
GB201503387D0 (en)	2015-04-15	Anti-carbapenem antibodies and uses thereof
CL2015003169A1 (es)	2016-05-13	Anticuerpos anti-cd38 y fusiones con interferón alfa-2b atenuado
HK1237252A1 (en)	2018-04-13	Interferon alpha and omega antibody antagonists